By Marlene Busko
December 30, 2016 – DANVILLE, PA and TARRYTOWN, NY — Genetic testing of more than 50 000 adult patients in a large US healthcare system identified that 1 in 222 patients carried gene variants associated with familial hypercholesterolemia (FH), in a new study. Moreover, these FH carriers were much more likely to have CAD or premature CAD. However, only three in five of these FH carriers were currently using statins, and only two in five had an LDL-cholesterol level below 100 ng/mL, the recommended target for adults with FH according to the National Lipid Association’s expert panel.
READ FULL STORY …